Cara Therapeutics
Katlyn McBergin is a Clinical Data Manager II and Lead Clinical Trial Associate at Cara Therapeutics. Prior to this, Katlyn served as a Regulatory Manager at Yale University, where Katlyn provided regulatory support for over 100 investigational drug trials and ensured compliance with FDA regulations. With experience as a Biology Teacher at Joseph A. Foran High School and roles in clinical research at Columbia University Medical Center and Boehringer Ingelheim, Katlyn has a strong background in education and regulatory compliance in the healthcare industry.
Cara Therapeutics
3 followers
Cara Therapeutics is an early commercial-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs.